AcuraStem
PrivateLast Round
Early Stage
VC
Jun 22, 2026
Total Funding Raised
$26.73M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AcuraStem is a biotechnology company that develops therapeutics for neurodegenerative diseases using its proprietary iNeuroRx® disease-modeling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcuraStem Comparables
Compare AcuraStem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuCyte | 88% | |
| Modulo Bio | 86% | |
| Quiver Bioscience | 84% |
AcuraStem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 22, 2026 | ||||
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 10, 2026 | ||||
| Grant | Sep 3, 2024 | ||||
| Grant | Jan 30, 2024 | ||||
Grant | Dec 15, 2021 |
Key People
Founding team and executive leadership
AcuraStem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| Viva BioInnovator | Grant |
| Target ALS | Grant |
| California Institute for Regenerative Medicine | Grant |
| National Institute on Aging | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 157% MoM, reaching 1.5K.
- Jun 22, 2026
Raised an Early Stage VC round.
AcuraStem Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AcuraStem's valuation, stock price, and market status.
Is AcuraStem a public or private company?
AcuraStem is a private company.
What is the current stock price of AcuraStem?
AcuraStem is a private company with no public stock price. No recent secondary market data is available.
How much is AcuraStem worth (valuation)?
Valuation information for AcuraStem is not publicly available.
Can I buy AcuraStem stock?
AcuraStem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AcuraStem's last funding round?
AcuraStem's most recent funding round was Early Stage VC on June 22, 2026.
Who are the main investors in AcuraStem?
Key investors in AcuraStem include United States Department of Defense, NIH RADx, Target ALS, California Institute for Regenerative Medicine, National Institute on Aging.
Will AcuraStem IPO soon?
No public IPO plans have been announced for AcuraStem.
How can I track AcuraStem secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AcuraStem's secondary market activity and sign up for updates.